Date: 2026-04-03 Quarter: Q4 FY26 (ended January 31, 2026; reported March 3, 2026) Market cap: $3.85B | EV: $2.59B | EV/TTM Rev: 2.7x | Revenue growth: 23.2% YoY
GitLab delivered a clean beat on Q4 (revenue +3.5% vs guide, non-GAAP EPS $0.30 vs $0.23 consensus) but the story is the FY27 guide-down: 15-17% revenue growth, ~500 bps operating margin compression, and EPS of 0.76−0.80 vs. Street's $1.05. The deceleration is mathematically defensible (300 bps non-recurring tailwinds, ratable model math, DBNR headwind) but represents a structural growth step-down from 26% to mid-teens with no near-term catalyst for reacceleration. The stock at 2.7x EV/TTM revenue is pricing in the worst case. I see a company with legitimate platform positioning in agentic AI, approaching GAAP profitability, with $1.3B cash, zero debt, and 89% non-GAAP gross margins — but needing 2-3 quarters to prove the new management team can execute. Conviction: 2.5/5 — interesting at this valuation but thesis is unproven.
| Criterion | Threshold | Actual | Pass/Fail |
|---|---|---|---|
| Revenue YoY growth | >30% | 23.2% (Q4), 26% (FY26), guide 16% (FY27) | FAIL |
| Gross margin | >60% | 86.6% GAAP / 89.0% Non-GAAP | PASS |
| Revenue per quarter | >$50M | $260.4M | PASS |
| Data availability | 4+ quarters | 16 quarters | PASS |
| Share dilution | <10% annual | 3.8% basic YoY | PASS |
| GAAP profitability trajectory | Improving or positive | Op margin: -9.1% to -2.0% YoY; near breakeven | PASS |
Gate assessment: Revenue growth fails the 30% threshold and is decelerating into mid-teens on guidance. This is a $955M revenue company approaching $1B ARR — law of large numbers applies, but the growth profile no longer qualifies as hyper-growth. I proceed with the full analysis because (a) this is a requested earnings review, (b) the valuation is deeply compressed, and (c) there are legitimate catalysts (DAP, go-to-market rebuild) that could reaccelerate growth in FY28.
| Factor | Rating | Detail |
|---|---|---|
| Growth | Weak | 23.2% YoY Q4, decelerating from 29.1% a year ago; FY27 guide 15-17%. Below 30% threshold. |
| Trajectory | Decelerating | Revenue YoY: 33.3% → 30.8% → 30.9% → 29.1% → 26.8% → 29.2% → 24.7% → 23.2%. Clear multi-year deceleration. FY27 guide accelerates the decline. |
| Margins | High | GAAP GM 86.6% (declining); Non-GAAP GM 89%; Non-GAAP op margin 20.5% (expanding). But FY27 guide: GM 85-87%, op margin 12-13%. Deliberate margin compression incoming. |
| Dominance | Strong | #2 DevSecOps platform globally. Gartner Leader 3 consecutive years, #1 in 4/6 Critical Capabilities. GitHub dominant in SCM (38% vs 16%) but GitLab owns enterprise security/compliance niche. |
| Valuation | Cheap | EV/TTM Rev 2.7x for a 23% grower with 89% gross margins. EV/NTM Rev ~2.3x on FY27 guide. Non-GAAP P/E 23.6x TTM. Cash = 33% of market cap. Near 52-week low. |
| Special | Present | (1) DAP/agentic AI optionality with zero revenue baked in; (2) $400M buyback = 10.4% of market cap; (3) new management from New Relic/Salesforce playbook; (4) 74% below ATH creates asymmetric setup if execution improves. |
| Fiscal Q | Calendar | Revenue ($m) | QoQ % | YoY % | Incr Rev ($m) |
|---|---|---|---|---|---|
| Q1_FY23 | Apr-22 | 87.4 | — | — | — |
| Q2_FY23 | Jul-22 | 101.0 | +15.6% | — | +13.6 |
| Q3_FY23 | Oct-22 | 113.0 | +11.9% | — | +12.0 |
| Q4_FY23 | Jan-23 | 122.9 | +8.8% | — | +9.9 |
| Q1_FY24 | Apr-23 | 126.9 | +3.3% | +45.2% | +4.0 |
| Q2_FY24 | Jul-23 | 139.6 | +10.0% | +38.2% | +12.7 |
| Q3_FY24 | Oct-23 | 149.7 | +7.2% | +32.5% | +10.1 |
| Q4_FY24 | Jan-24 | 163.8 | +9.4% | +33.3% | +14.1 |
| Q1_FY25 | Apr-24 | 169.2 | +3.3% | +33.3% | +5.4 |
| Q2_FY25 | Jul-24 | 182.6 | +7.9% | +30.8% | +13.4 |
| Q3_FY25 | Oct-24 | 196.0 | +7.3% | +30.9% | +13.4 |
| Q4_FY25 | Jan-25 | 211.4 | +7.9% | +29.1% | +15.4 |
| Q1_FY26 | Apr-25 | 214.5 | +1.5% | +26.8% | +3.1 |
| Q2_FY26 | Jul-25 | 236.0 | +10.0% | +29.2% | +21.5 |
| Q3_FY26 | Oct-25 | 244.4 | +3.6% | +24.7% | +8.4 |
| Q4_FY26 | Jan-26 | 260.4 | +6.5% | +23.2% | +16.0 |
| Fiscal Q | Calendar | GM % | Op Margin % | Net Margin % | Non-GAAP Op % |
|---|---|---|---|---|---|
| Q1_FY24 | Apr-23 | 89.0% | -45.9% | -41.4% | — |
| Q2_FY24 | Jul-23 | 89.5% | -38.8% | -35.9% | — |
| Q3_FY24 | Oct-23 | 89.9% | -26.9% | -190.5%* | — |
| Q4_FY24 | Jan-24 | 90.2% | -21.3% | -23.2% | — |
| Q1_FY25 | Apr-24 | 88.9% | -31.7% | -32.6% | — |
| Q2_FY25 | Jul-24 | 88.3% | -22.5% | +7.1% | — |
| Q3_FY25 | Oct-24 | 88.7% | -14.6% | +14.8% | — |
| Q4_FY25 | Jan-25 | 89.2% | -9.1% | +3.3% | 17.7% |
| Q1_FY26 | Apr-25 | 88.3% | -16.1% | -16.7% | — |
| Q2_FY26 | Jul-25 | 87.9% | -7.8% | -3.9% | — |
| Q3_FY26 | Oct-25 | 86.8% | -5.1% | -3.4% | — |
| Q4_FY26 | Jan-26 | 86.6% | -2.0% | -1.0% | 20.5% |
Q3_FY24 net margin anomaly from IP restructuring tax provision.
| Fiscal Q | GAAP EPS | Non-GAAP EPS | Basic Shares (M) |
|---|---|---|---|
| Q4_FY25 | $0.04 | $0.33 | 163.1 |
| Q4_FY26 | -$0.02 | $0.30 | 169.3 |
| FY26 | -$0.34 | $0.96 | 166.8 |
| Fiscal Q | FCF ($m) | FCF Margin % |
|---|---|---|
| Q1_FY25 | 37.4 | 22.1% |
| Q4_FY25 | 62.1 | 29.4% |
| Q1_FY26 | 105.4 | 49.1% |
| Q4_FY26 | 41.8 | 16.1% |
| FY26 total | 219.6 | 23.0% |
This is Atlas's first analysis of GTLB — no prior beliefs exist. Using pre-earnings consensus and guidance as the baseline.
| Metric | Pre-Q4 Expectation | Actual | Verdict |
|---|---|---|---|
| Q4 Revenue | $251.5M (guide mid) | $260.4M (+3.5% beat) | Strong beat |
| Q4 Non-GAAP Op Margin | ~15% implied | 20.5% | Significant upside |
| Q4 Non-GAAP EPS | $0.23 consensus | $0.30 (+30% beat) | Strong beat |
| Q4 cRPO | ~$700M implied | $719.4M (+24% YoY) | Solid; accelerated from Q3's +22% |
| Q4 NRR | ~119% (trend) | 118% (-1pp QoQ) | In-line with decline trend |
| Q4 $1M+ Customers | ~145 implied | 155 (+26% YoY) | Record adds; strongest cohort |
| FY27 Revenue Guide | ~$1.2B+ Street | 1, 099−1,118M (15-17%) | Significant miss |
| FY27 EPS Guide | ~$1.05 consensus | 0.76−0.80 | 24% miss — the catalyst for the sell-off |
| FY27 Gross Margin Guide | ~89% (flat) | 85-87% | Mix shift compression flagged |
Delta assessment: The quarter itself was excellent — revenue beat, margin beat, record $1M+ customer adds, cRPO accelerating. The problem is forward guidance. The ~10pp deceleration in revenue growth (26% to 16%) and ~500 bps op margin compression are material. Management attributes this to (1) 300 bps non-recurring tailwinds, (2) ratable model math, (3) deliberate investment in go-to-market, (4) conservative DAP assumptions. This is credible but requires trust in a brand-new management team. The -9.85% after-hours reaction was driven entirely by the forward guide, not the backward-looking results.
| Metric | Q4_FY25 | Q2_FY26 | Q3_FY26 | Q4_FY26 | Trend |
|---|---|---|---|---|---|
| cRPO YoY | — | — | +22% est | +24.2% | Accelerating |
| Revenue YoY | 29.1% | 29.2% | 24.7% | 23.2% | Decelerating |
| RPO YoY | — | — | — | +16.4% | — |
cRPO growing at 24.2% vs. revenue at 23.2% is a mild bullish divergence — bookings in the current recognized obligation window are outpacing revenue. RPO at +16.4% is weaker (long-dated contracts growing slower), but the cRPO signal is what matters for near-term revenue.
| Metric | Q4_FY25 | Q2_FY26 | Q3_FY26 | Q4_FY26 | Trend |
|---|---|---|---|---|---|
| DBNR | 123% | 121% | 119% | 118% | Declining (-2pp/Q avg) |
| $1M+ Customers YoY | — | — | — | +26% | Strong |
| $100K+ Customers YoY | — | — | — | +18% | Healthy |
| Gross Retention | — | — | — | >90% (4-yr best) | Improving |
This is an unusual pattern. The enterprise segment ($100K+, $1M+) is expanding rapidly while aggregate NRR declines. The explanation is a bifurcation: enterprise healthy, price-sensitive cohort (~20% of ARR) contracting or flat. CFO guided NRR to "trend down slightly before stabilizing" — I expect 115-116% by mid-FY27 before any DAP-driven recovery.
Mixed. cRPO mildly bullish for near-term revenue. NRR decline is sustained and not yet bottomed per management's own guidance. The $1M+ customer acceleration is the strongest single leading indicator — large enterprise deals are the future revenue backbone. But the SMB/mid-market weakness in NRR is a drag that requires the go-to-market rebuild to address.
| Metric | Current | 1Y Ago (est) | Peer Median | Assessment |
|---|---|---|---|---|
| EV/TTM Revenue | 2.7x | ~8-10x | ~6x | Cheap — deep discount to peers |
| EV/TTM Gross Profit | 3.1x | ~9-11x | ~8x | Cheap |
| EV/FY27 Revenue (NTM) | 2.3x | — | ~5x | Cheap |
| Non-GAAP P/E (TTM) | 23.6x | — | ~40-50x | Cheap |
| Fwd Non-GAAP P/E (FY27) | 29.0x | — | ~35-45x | Fair |
| Market cap | $3.85B | ~$8-10B | — | Down 74% from ATH |
| Cash + investments | $1.26B | $0.99B | — | 33% of mkt cap |
| Net cash | $1.26B (no debt) | — | — | Fortress balance sheet |
| Rule of 40 | 42.3 | ~35-40 | ~35 | Healthy |
Relative valuation: At 2.7x EV/TTM revenue for a company growing 23% with 89% non-GAAP gross margins and positive FCF, GitLab is trading at a significant discount to DevOps/security peers (Datadog ~15x, CrowdStrike ~20x, even slower-growth names at 5-8x). The discount reflects: (1) growth decelerating into mid-teens, (2) new management team unproven, (3) margin compression ahead, (4) NRR declining. But even on FY27's guided 16% growth, 2.3x EV/NTM revenue is cheap. Cash at 33% of market cap provides a floor.
Growth-adjusted view: EV/TTM Rev / YoY growth = 2.7x / 23% = 0.12x — anything below 0.5x is attractive on a PEG-like basis for a high-gross-margin SaaS company. Even on the FY27 guided 16% growth: 2.3x / 16% = 0.14x. The market is pricing this as if growth falls below 10%.
Secular trend: GitLab sits at the intersection of two megatrends: (1) DevSecOps consolidation — enterprises replacing point solutions with integrated platforms, and (2) agentic AI for software development — agents writing, testing, reviewing, and deploying code need infrastructure to operate within.
Platform vs. point solution: GitLab is a genuine platform. The full lifecycle — plan, create, verify, package, secure, deploy, monitor, govern — is integrated. 56% of ARR on Ultimate tier indicates customers buy the whole platform, not individual features. The DAP launch extends this into AI-native workflows with usage-based monetization.
TAM penetration: GitLab's ~$955M in revenue against a DevSecOps TAM estimated at $45-65B (depending on inclusion of AI tooling) suggests <2% penetration. The agentic AI layer expands TAM further — every agent action (code review, vulnerability scan, compliance check) becomes a monetizable event.
Self-managed to SaaS transition: 70% of revenue still from self-managed deployments. This is both a moat (enterprises with data sovereignty needs) and a drag (slower feature adoption, DAP rollout gated by upgrade cycles). SaaS at 32% and growing 38% YoY is the right direction but will take years to flip.
NRR continues declining past 115%. The price-sensitive cohort (~20% of ARR) is not expanding. If this spreads to mid-market or if DAP credits do not drive re-engagement, NRR could fall to 110%, mathematically constraining revenue growth below 15%.
New management execution failure. CEO (14 months), CFO (3 months) — this is an effectively new team. Blind reviews suggest cultural friction. If engineering attrition accelerates or go-to-market rebuild misses the H2 FY27 ramp target, the "transition year" narrative extends into FY28.
DAP monetization disappoints. Management explicitly pushed material DAP revenue to FY28. If the self-managed upgrade cycle takes longer than 6 months, or if usage-based pricing generates less per seat than expected, the AI thesis derates.
Gross margin compression accelerates. Guided 85-87% non-GAAP GM for FY27 (vs. 89% FY26). If the SaaS/Dedicated/DAP mix shift pushes below 85%, the margin profile starts looking more like a services business than a pure software company.
GitHub/Microsoft competitive pressure. GitHub Copilot with GPT-5, model-agnostic approach, and broader developer ecosystem could erode GitLab's enterprise wins, especially if Microsoft bundles security features into GitHub Enterprise at competitive pricing.
DAP adoption inflection (H2 FY27 to FY28). If even 20-30% of GitLab's enterprise base converts pilots to committed DAP credits, the incremental revenue (usage-based on top of seat licensing) could add 3-5pp to growth.
Go-to-market ramp pays off (Q3 FY27+). Management entering FY27 with "highest sales capacity ever" and expects step-function increase in ramped capacity ~Q3 FY27. If bookings reaccelerate in H2, cRPO and revenue follow in FY28.
**400Mbuybackexecution. * *Atcurrentprices( 23), $400M buys back ~10% of shares outstanding. Highly accretive if stock stays depressed.
NRR stabilization. If NRR bottoms at 115-116% and the market removes the "NRR death spiral" discount, re-rating potential is significant. Gross retention at 4-year highs (>90%) suggests churn is not the issue — it is expansion.
GAAP profitability milestone. Operating loss narrowed to -$5.2M in Q4 (-2.0% margin). One more quarter of improvement could deliver GAAP operating breakeven.
Analysis by Atlas. First coverage of GTLB. No prior position.